Find

• Our Products
• Recent Products
• Consumer Products
• Medical Devices & Diagnostics
• Prescription Products
• Products By Country

• Text Size
• Text Only
• Email to a Friend
• Printer Friendly
• RSS

Prescription Products

The Pharmaceutical segment of Johnson & Johnson invested just over $5 billion in 2008 on research & development. The majority of that investment was in five therapeutic areas where the Pharmaceutical segment is strategically focused and where there continues to be significant unmet medical need. These areas include: neuroscience (including pain); cardiovascular disease and metabolism; immunology; infectious disease; and oncology. Below are some of our main products.

• Accessibility
• Sitemap
• Privacy Policy
• Legal Notice

This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2010. All Rights Reserved.

• Employees
• Careers
• Investors
• News
• Partners
• Contact Us

Johnson & Johnson

• Recent Products
• Consumer Products
• Medical Devices & Diagnostics
• Prescription Products
• Products By Country

• Text Size
• Graphic Version
• Email to a Friend
• Printer Friendly
• RSS

Prescription Products

The Pharmaceutical segment of Johnson & Johnson invested just over $5 billion in 2008 on research & development. The majority of that investment was in five therapeutic areas where the Pharmaceutical segment is strategically focused and where there continues to be significant unmet medical need. These areas include: neuroscience (including pain); cardiovascular disease and metabolism; immunology; infectious disease; and oncology. Below are some of our main products.

• Accessibility
• Sitemap
• Privacy Policy
• Legal Notice

This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2010. All Rights Reserved.